Lantheus Acquires Meilleur Technologies, Including The NAV-4694 SS Amyloid PET Imaging Agent For Alzheimer's Disease; Financial Terms Not Disclosed
Lantheus Acquires Meilleur Technologies, Including The NAV-4694 SS Amyloid PET Imaging Agent For Alzheimer's Disease; Financial Terms Not Disclosed
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.